Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07375095Completed
Randomised, double-blind trial in sleep disorder, sponsored by Bonafide Health. Primary endpoints: Patient-Reported Outcomes Measurement Information System Sleep Disturbance Short Form 8b T-score at 3 weeks, Responder Rate for Patient-Reported Outcomes Measurement Information System Sleep Disturbance Short Form 8b at 3 weeks and 2 more. Started Oct 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07375095.